In a recent open‐label study, twice‐daily application of SMFE for 1 year in patients with mild‐to‐moderate facial acne demonstrated good tolerability and led to sustained, highly significant reductions in lesion counts, clinical scores, and other efficacy markers over several months.
← all excerpts
Aesthetic Medicine Management and the Role of Dermocosmetics for Acne-Prone Skin: A (Narrative) Mini Review.
1
—
—